兔抗CLN5多克隆抗體

Background:

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.

Applications:

ELISA, WB, IHC

Name of antibody:

CLN5

Immunogen:

Synthetic peptide of human CLN5

Full name:

ceroid-lipofuscinosis, neuronal 5

Synonyms:

NCL

SwissProt:

O75503

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer

IHC Recommend dilution:

40-200

WB Predicted band size:

41 kDa

WB Positive control:

231 cell lysate

WB Recommended dilution:

200-1000